RecruitingNot ApplicableNCT05182229

Comparing Two Ways to Manage Head and Neck Lymphedema

Comparing Two Ways to Manage Lymphedema in Head and Neck Cancer Survivors


Sponsor

Abramson Cancer Center at Penn Medicine

Enrollment

300 participants

Start Date

Mar 11, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two methods of managing lymphedema (swelling caused by fluid buildup) in the head and neck area after head and neck cancer treatment: in-person therapy sessions versus telehealth (video-based) sessions from home. **You may be eligible if:** - You are 18 years or older - You finished head and neck cancer treatment within the past 24 months - You have been diagnosed with head and neck lymphedema and referred by your cancer care team - You are able to perform self-massage (manual lymphatic drainage) on yourself - You have a computer, tablet, or smartphone with internet access at home **You may NOT be eligible if:** - You have an active soft tissue infection in the head or neck area - You have a history of moderate or severe carotid artery blockage - Your lymphedema is very severe (such as extreme swelling around the eyes) - You have a condition that makes lymphedema therapy unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHome-based (a hybrid model) CDT

Participants will be provided therapist-administered, in person complete decongestive therapy (CDT) two times per week for two weeks (4 sessions), followed by real-time, virtual CDT consultations two times per week for three weeks (7 sessions) and one in person follow-up visit.

OTHERClinic-based CDT

Participants will be provided therapist administered, in-person CDT two times per week for six weeks (12 sessions).


Locations(6)

Jefferson Cherry Hospital Jefferson Health

Cherry Hill, New Jersey, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Jefferson Health

Philadelphia, Pennsylvania, United States

Jefferson Torresdale Hospital Jefferson Health

Philadelphia, Pennsylvania, United States

Temple University Hospital and Fox Chase Cancer Center

Philadelphia, Pennsylvania, United States

Asplundh Cancer Pavilion Jefferson Health

Willow Grove, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05182229


Related Trials